Skip to content

Association study of Helicobacter pylori infection with the progression coronary artery calcification

Association study of Helicobacter pylori infection with the progression coronary artery calcification

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076173
Enrollment
Unknown
Registered
2023-09-26
Start date
2023-09-26
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary atherosclerotic heart disease

Interventions

H. pylori-positive group:NA
H. pylori-negative group:NA

Sponsors

Beijing Rehabilitation Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Over 35 years old; patients underwent health examinations at our hospital for three consecutive years; The examination items include 7 items of liver function, 3 items of kidney function, 4 items of blood lipids, and carbon 13 urea breath test; coronary artery CT angiography examination annually

Exclusion criteria

Exclusion criteria: Severe renal insufficiency; After old myocardial infarction or coronary stent implantation; After coronary artery bypass grafting; Taking lipid-lowering drugs; Take antibiotics within 1 month; Take H. pylori sensitive drugs such as acid suppressants and bismuth preparations within 2 weeks; After gastrectomy or partial gastrectomy; Concomitant acute and chronic infections; Merging autoimmune diseases; Combined thyroid and adrenal dysfunction; Reject participants.

Design outcomes

Primary

MeasureTime frame
carbon 13 urea breath test;coronary artery CT angiography examination ;Helicobacter pylori antibody typing test;

Secondary

MeasureTime frame
blood lipids; liver function; kidney function;

Countries

China

Contacts

Public ContactWang Minghu

Beijing Rehabilitation Hospital of Capital Medical University

wangminghu23@163.com+86 173 1600 5595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026